Trailing-twelve-month (TTM) revenue is $14.91 Billion with a year-over-year growth of +5.24%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,690,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $3,796,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q1 FY2026Period ended 2026-03-31 | $3,566,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $3,859,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $14,911,000,000 |
Current P/S: $26,151,983,589 market capitalization ÷ $14,911,000,000 TTM revenue = 1.75x.
Market capitalization source: FMP quote. Quote observed 2026-09-17T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.86B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-17T20:25:55.532Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| New Equipment | $5.4B | $6.4B | $5.9B | $5.8B | $5.4B | $5.0B |
| Services | $7.4B | $7.9B | $7.8B | $8.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $2.1B | $2.9B | $2.6B | $2.4B | $1.9B | $1.6B |
| Other | $7.2B | $7.7B | $7.3B | $7.7B |
$14.91B
$14.91 Billion
+5.24%
vs. $14.17B a year ago (TTM)
+1.46%
5 Year compound annual growth rate
1 Year
+5.24%
3 Year
+2.49%
5 Year
+1.46%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $14.43B | +$170.00M | +1.19% |
| 2024 | $14.26B | +$52.00M | +0.37% |
| 2023 | $14.21B | +$524.00M | +3.83% |
| 2022 | $13.69B | ($613.00M) | (4.29%) |
| 2021 | $14.30B | +$1.54B | +12.09% |
| 2020 |
TTM Growth
+5.24%
3-Year CAGR
+2.49%
5-Year CAGR
+1.46%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-17T20:25:55.532Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $8.9B |
| $9.4B |
| $8.6B |
| UNITED STATES | $3.5B | $3.7B | $3.8B | $4.0B | $4.2B | $4.2B |
|---|
| $12.76B |
| ($362.00M) |
| (2.76%) |
| 2019 | $13.12B | +$203.00M | +1.57% |
| 2018 | $12.91B | +$592.00M | +4.80% |
